CPT code 17107 represents laser or other nonincisional destruction of a cutaneous vascular proliferative lesion measuring 10.0 cm2 to 50.0 cm2. This code captures a common dermatologic, bloodless surgical approach for treating vascular lesions such as port-wine stains, hemangiomas, or telangiectatic proliferations when the affected area falls within the specified size range. Nationally, accurate use of this code matters for consistent clinical documentation, appropriate billing, and aggregated tracking of procedural volume for dermatologic laser services.

Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, common modifiers used with this service, and how payers commonly categorize and reimburse laser-based cutaneous vascular destruction. The publication also summarizes benchmarking considerations and coding nuances related to lesion size thresholds and service reporting.

This briefing is intended to orient clinicians, billing professionals, and policy analysts to the clinical definition and billing context of CPT code 17107, and to highlight the areas where payers and providers commonly focus reconciliation and policy review.